Goldberg Mark Alan
Director at ImmunoGen, Inc.; Director at BPMC; EVP, Medical & Reg. Strategy at TRIMERIS INC
- Sold, on record
- $8.5M
- Dollars the filings state
- Form 4 sales
- 16
- Latest Dec 24, 2020
- Form 144 notices
- 1
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- ImmunoGen, Inc.Director
- BPMCBlueprint Medicines CorpDirector
- TRIMERIS INCEVP, Medical & Reg. Strategy
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- TRIMERIS INC74,633 shares
- BPMC32,727 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale TRIMERIS INCUnusualSep 19, 2014 2014
Sold 790 shares at $65.24 ($52k)
Goldberg Mark Alan, EVP, Medical & Reg. Strategy
Sold 58.4% of holdings ($88k position)562 shares left0.1x usual sizeFiling
- 2 Form 4 sale BPMCUnusualOct 7, 2020 +2210 days
Sold 5,454 shares at $100.00 ($545k)
Goldberg Mark Alan, Director
Sold 60.5% of holdings ($902k position)3,562 shares leftFirst sale on recordFiling
- 3 Form 4 sale BPMCUnusualOct 19, 2020 +12 days
Sold 5,455 shares at $105.00 ($573k)
Goldberg Mark Alan, Director
Sold 60.5% of holdings ($947k position)3,562 shares leftFiling
- 4 Form 4 sale BPMCUnusualDec 1, 2020 +43 days
Sold 5,454 shares at $110.00 ($600k)
Goldberg Mark Alan, Director
Sold 60.5% of holdings ($992k position)3,562 shares leftFiling
- 5 Form 4 sale BPMCUnusualDec 11, 2020 +10 days
Sold 5,455 shares at $115.00 ($627k)
Goldberg Mark Alan, Director
Sold 60.5% of holdings ($1M position)3,562 shares left1x usual sizeFiling
- 6 Form 4 sale BPMCUnusualDec 18, 2020 +7 days
Sold 5,454 shares at $120.00 ($654k)
Goldberg Mark Alan, Director
Sold 60.5% of holdings ($1.1M position)3,562 shares left1x usual sizeFiling
- 7 Form 4 sale BPMCUnusualDec 24, 2020 +6 days
Sold 5,455 shares at $125.00 ($682k)
Goldberg Mark Alan, Director
Sold 60.5% of holdings ($1.1M position)3,562 shares left1x usual sizeFiling
- 8 Form 144 notice ImmunoGen, Inc.NoticeOct 30, 2023 +1040 days
Filed to sell 10,000 shares ($151k)
Goldberg Mark Alan, Director
10b5-1 planFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (17)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 30, 2023 | Oct 30, 2023 | ImmunoGen, Inc. | Director | Form 144 notice | 10,000 | $151k | Notice | SEC | |
| Dec 24, 2020 | Dec 28, 2020 | BPMC | Director | Form 4 sale | 5,455 | $682k | 60.5% | Unusual | SEC |
| Dec 18, 2020 | Dec 22, 2020 | BPMC | Director | Form 4 sale | 5,454 | $654k | 60.5% | Unusual | SEC |
| Dec 11, 2020 | Dec 15, 2020 | BPMC | Director | Form 4 sale | 5,455 | $627k | 60.5% | Unusual | SEC |
| Dec 1, 2020 | Dec 3, 2020 | BPMC | Director | Form 4 sale | 5,454 | $600k | 60.5% | Unusual | SEC |
| Oct 19, 2020 | Oct 21, 2020 | BPMC | Director | Form 4 sale | 5,455 | $573k | 60.5% | Unusual | SEC |
| Oct 7, 2020 | Oct 9, 2020 | BPMC | Director | Form 4 sale | 5,454 | $545k | 60.5% | Unusual | SEC |
| Sep 19, 2014 | Sep 19, 2014 | TRIMERIS INC | EVP, Medical & Reg. Strategy | Form 4 sale | 790 | $52k | 58.4% | Unusual | SEC |
| Sep 17, 2014 | Sep 18, 2014 | TRIMERIS INC | EVP, Medical & Reg. Strategy | Form 4 sale | 13,579 | $883k | 96.0% | Unusual | SEC |
| Jun 11, 2014 | Jun 12, 2014 | TRIMERIS INC | EVP, Medical & Reg. Strategy | Form 4 sale | 21,597 | $1.7M | 97.9% | Unusual | SEC |
| Dec 3, 2013 | Dec 4, 2013 | TRIMERIS INC | SVP,Medical&Regulatory Affairs | Form 4 sale | 7,000 | $424k | 96.3% | Unusual | SEC |
| Nov 1, 2013 | Nov 4, 2013 | TRIMERIS INC | SVP,Medical&Regulatory Affairs | Form 4 sale | 7,000 | $350k | 96.3% | Unusual | SEC |
| Oct 1, 2013 | Oct 3, 2013 | TRIMERIS INC | SVP,Medical&Regulatory Affairs | Form 4 sale | 7,000 | $450k | 96.3% | Unusual | SEC |
| Apr 1, 2013 | Apr 3, 2013 | TRIMERIS INC | SVP,Medical&Regulatory Affairs | Form 4 sale | 4,416 | $240k | 100.0% | Unusual | SEC |
| Mar 1, 2013 | Mar 6, 2013 | TRIMERIS INC | SVP, Product Development | Form 4 sale | 4,417 | $224k | 100.0% | Unusual | SEC |
| Feb 1, 2013 | Feb 5, 2013 | TRIMERIS INC | SVP, Product Development | Form 4 sale | 4,417 | $211k | 100.0% | Unusual | SEC |
| Jan 2, 2013 | Jan 4, 2013 | TRIMERIS INC | SVP, Product Development | Form 4 sale | 4,417 | $210k | 100.0% | Unusual | SEC |